Product Name: LY210976 | TGF-β receptor type I/II inhibitor
Product Description: LY-2109761 is an orally-bioavailable pyrrolopyrazole inhibitor of the TGF-b1/2 kinase subtypes in Phase I and II clinical studies for malignant malignancies. With Ki potencies of 38 nM and 300 nM, respectively, LY-2109761 has been studied in metastatic paWeb Site：Medchemexpress
Chemical Formula: C26H27N5O2
Molecular Weight: 441.52
‘&“CAS NO: 1801747-11-4 SHP099 (hydrochloride)
Purity: 98%
Appearance: Pale Brown
Chemical Name: 7-(2-morpholinoethoxy)-4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolineCasein Kinase inhibitors
Solubility: Up to 100 mM in DMSO
Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage Condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.PubMed ID:http://www.nature.com/srep/2011/110818/srep00070/full/srep00070.html
